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Optical diagnosis techniques offer several advantages over traditional approaches, including 
objectivity, speed and cost, and these label-free, non-invasive methods have the potential to change 
the future work-flow of cancer management. The oral cavity is particularly accessible and thus such 
methods may serve as alternate/adjunct tools to traditional methods. Recently, in vivo human clinical 
studies have been initiated with a view to clinical translation of such technologies. A comprehensive 
review of optical methods in oral cancer diagnosis is presented. Following an introduction to the 
epidemiology and aetiological factors associated with oral cancers currently employed diagnostic 
methods and their limitations are presented. A thorough review of fluorescence, infrared absorption 
and Raman spectroscopic methods in oral cancer diagnosis is presented. The applicability of 
minimally invasive methods based on serum/saliva is also discussed. The review concludes with a 
discussion on future demands and scope of developments from a clinical point of view.  
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Oral Cancers: An Overview  
Oral squamous cell carcinoma (OSCC) ranks as the 15
th
 most common cancer in the world and 10
th
 
most frequent in males. It accounts for ~2.1% of total cancer cases worldwide. Incidence rates are 
high among males in south central Asia and among females in eastern and central Europe
1
. Although 
mortality from oral cancer has decreased in the past few decades, it is still high and has a five year 
survival rate of 50%
2
. Several oral lesions and conditions are associated with an increased potential 
for malignant transformation. Of these, the most commonly occurring is leukoplakia, defined as ‘a 
predominantly white lesion of the oral mucosa that cannot be characterized as any other definable 
lesion’ (Figure 1B). A wide range of malignant transformation rates have been reported, from 0.13-
36.43%, depending on the presence and degree of dysplasia, location in the oral cavity and maturity of 
the lesion
3,4
. Conversely, erythroplakia, defined as ‘a fiery red patch which cannot be characterized 
clinically or pathologically as any other definable lesion’3, is less prevalent and has a higher potential 
for malignant transformation (14.35-66.76 %)
5
. Oral submucous fibrosis is a premalignant oral 
condition arising mostly due to areca nut or betel quid chewing
6
. It has a reported transformation rate 
of 7.6%
6
. Oral lichen planus is an inflammatory disease of the oral mucosa. Like leukoplakia, it 
presents as a white plaque or patch. However, its malignant transformation rate is much lower than 
leukoplakia, ~1%
7
 (Figure 1C).  
A number of risk factors are associated with oral cancer, including cigarette smoking and alcohol 
consumption, which are responsible for 42% and 16% of oral cancer deaths respectively
8
. The 
carcinogenicity of cigarette smoke has long been established, resulting in DNA damage and increase 
in P53 mutations
9
. The association between alcohol and oral cancer was reported to be dose dependent 
and a number of factors may contribute to its carcinogenicity, including acetaldehyde, an alcohol 
metabolite thought to be carcinogenic
10
. Moreover, alcohol is thought to act as a solvent for other 
carcinogens
10
. Oral habits such as smokeless tobacco and betel quid chewing are also implicated in 
oral cancer development
11
. They are more common in the Asian population; in India, 50% of oral 
cancers arise due to smokeless tobacco chewing
11
. The carcinogenicity of smokeless tobacco arises 
from the production of nitrosamines
11
. Oral squamous cell carcinoma has also been associated with 
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the Epstein Bar (EBV) and Human Papilloma (HPV) Viruses, although their putative role is 
controversial. Around 23% of OSCC were found to be positive for high risk HPV 16 and 18 
12
.  
Current Screening/Diagnostic methods and limitations: 
Screening tests or diagnostic aids presently available for oral cancer include conventional oral 
examination (COE), staining with toluidine blue, oral brush biopsy and scalpel biopsy coupled with 
histology. 
Conventional Oral Examination (COE): Conventional oral examination (COE), using normal 
(incandescent) light, has long been the standard screening method for oral abnormalities. As it is a 
visual method, it cannot identify early mucosal abnormalities that may or may not lead to oral cancer. 
Approximately 5-15% of the general population has oral mucosal abnormalities and the vast majority 
of these lesions are benign in nature 
13,
 Furthermore, only a small percentage of leukoplakias are 
progressive or become malignant and COE cannot discriminate between these and their non-
progressive counterparts. Therefore, while COE may be useful in discovering some oral lesions, its 
potential in identifying all potentially premalignant or biologically relevant lesions that are likely to 
progress to cancer is questionable.  
Toluidine blue staining: Toluidine blue (TB), has been used for more than 40 years as an aid to 
detection of mucosal abnormalities of the cervix and the oral cavity. TB is a metachromatic, 
acidophilic dye that binds preferentially to tissues undergoing rapid cell division (inflammatory, 
regenerative and neoplastic tissue), resulting in preferential staining of abnormal tissue. Overall, TB 
appears to be useful in detecting carcinomas, but is positive in only ~50% of lesions with dysplasia. In 
addition, it frequently stains common, benign conditions such as non-specific ulcers. The high rate of 
false positive stains and the low specificity in staining dysplasia are some of the accepted limitations 
of the technique 
14
.  
Oral brush biopsy: Oral brush biopsy extracts a complete trans-epithelial biopsy specimen, with 
cellular representation from each of the three layers (basal, intermediate and superficial). Because the 
brush biopsy detects only cellular atypia, positive results must be confirmed with a scalpel biopsy for 
definitive diagnosis.  This technique has therefore been criticized for adding time and cost to the 
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diagnosis of oral lesions without additional benefit to the patient
15
.  Overall, it is a method of 
identifying unsuspected oral cancers found during a visual examination, at early and curable stages
16
.
  
Histology: Histological risk stratification, currently the gold standard for oral cancer diagnosis, 
requires biopsy, staining and microscopic examination by a pathologist. However, removal of tissue 
or biopsy is an inherently invasive procedure and carries risk of complications in the proximity of 
vital anatomy. Sampling errors in collecting or interpreting biopsies due to inter-observer discrepancy 
can be significant. Once removed, the tissue can undergo biochemical changes which can lead to 
artifacts. In many diseases, tissue involvement is not uniform, potentially leading to sampling errors. 
Especially in oral cancers, some early lesions are clinically indistinguishable from benign conditions. 
Furthermore, histologically, identification of subtle changes in precancerous lesions or in normal 
mucosa that are indicative of early neoplastic transformation is subjective and can lead to inter-
observer variations 
17
. 
It is therefore conceivable that the primary prevention of the disease would involve activities to 
reduce or eliminate the use of tobacco and alcohol. Secondary prevention includes activities that are 
aimed to detect the disease at an early stage which would lead to better prognosis and lower 
morbidity. Current methods of detection of oral cancers are based largely on visual observations of 
abnormalities in tissue or cellular morphology and are therefore limited in terms of sensitivity and 
specificity, particularly at early stages. In the following section, a general discussion on the 
application of optical spectroscopic methods as an alternate/adjunct diagnostic tool for oral cancer is 
presented. 
Optical spectroscopy in oral cancer diagnosis 
Spectroscopy is the study of the frequency dependence of the interaction of electromagnetic radiation 
(light) with matter. Generally, light interacts with matter through absorption, emission and 
scattering/reflection. In each case, the spectrum of the interaction gives information about, and is 
characteristic of, the structure and chemical content of the sample. Optical measurements provide 
quantitative information based on the spectroscopic signature of the biochemical constituents of the 
sample that can be rapidly analyzed to yield an objective diagnosis, even in the hands of a non-expert 
operator. Diagnosis is based on biochemical changes underlying the pathology rather than visual or 
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microscopic changes in cellular or tissue morphology. Devices to make these measurements have 
become inexpensive, robust, and portable, because of advances in computing, optical, fiber-optical, 
and semiconductor technology. Approaches based on fluorescence, Fourier-transform infrared 
absorption and Raman scattering spectroscopy have shown potential for improved detection of oral 
cancers. A brief introduction of these techniques and their potential applications in oral cancer 
diagnosis is presented in the following sub-sections. Figure 2 provides a schematic illustration of their 
typical method of application.  
Fluorescence spectroscopy: When a molecule is illuminated at an excitation wavelength lying within 
the absorption spectrum of that molecule, it absorbs the energy and undergoes a transition from the 
ground state to an excited state. The molecule can then relax back from the excited state to the ground 
state by emission of light at specific emission wavelengths. In the UV/visible/Near infrared region of 
the spectrum (~200-1000nm), light emission takes the form of fluorescence (or occasionally 
phosphorescence). A fluorescence emission spectrum represents the fluorescence intensity measured 
over a range of emission wavelengths at a fixed excitation wavelength and can provide information 
relating to the molecular characteristics of the fluorophore, Figure 3.  
In the late 1970s, cancer diagnosis based on auto-fluorescence (also called natural, intrinsic or 
endogenous fluorescence) of naturally occurring fluorophores such as collagen, elastin, keratin and 
NADH was initiated 
18
. The presence of disease can lead to changes in blood concentration, nuclear 
size, collagen content or epithelial thickness, which can alter the concentration and characteristics of 
the fluorophores. In oral cancers, it was demonstrated that the epithelial layer shields the strongly 
fluorescing collagen layer leading to a low intensity of fluorescence in cancers
19
. An ex vivo study 
used hamster buccal pouch as an experimental model to identify spectral markers associated with 
different stages of oral carcinogenesis 
20
. Onizawa et al., compared fluorescence spectra from human 
and hamster biopsies and oral cancer cell lines, suggesting that variation in the riboflavin and 
porphyrin fluorescence can be used as a spectroscopic marker for normal and cancerous conditions
21
. 
Ingrams et al. further showed that normal and cancerous human biopsies can be discriminated based 
on their autofluorescence spectral profile
22
. Another ex vivo study by Muller et al., explored the 
feasibility of quantifying the spectroscopic response of different grades of malignancy
23
.   
7 
 
The first in vivo study using autofluorescence spectroscopy by Harris et al. reported differences 
between healthy and tumor mucosa based on the porphyrin emission band
24
. These differences were 
attributed to microorganisms living on ulcerating or necrotic surfaces. In vivo methods have also been 
explored to understand oral cancer progression in animal models
25
. Gillenwater et al. recorded in vivo 
autofluorescence from oral mucosa of 8 healthy volunteers and 15 patients with premalignant or 
malignant lesions
26
. Decreased intensity in the blue spectral regions, and increased porphyrin 
fluorescence in the red were observed. Based on the ratio between these, a sensitivity of 82% and 
specificity of 100% were reported 
26
. Various other studies have provided further evidence in support 
of in vivo fluorescence spectroscopy for non-invasive oral cancer diagnosis
27-29
. A recent study by 
Shaizu et al. showed that autofluorescence spectroscopy can be used to identify oral cavity disorders 
caused by long-term tobacco habits. Their findings suggest that lower collagen levels and increased 
ratios of flavin adenine dinucleotide (FAD) to nicotinamide adenine dinucleotide (NADH) can serve 
as prognostic markers for oral cancer risk 
30
.  
However, tissue contains few natural fluorophores and their spectroscopic features are broad and 
overlapping, making them poorly distinguishable, reducing the specificity of fluorescence 
spectroscopy for diagnostic applications. 
Fourier-transform infrared spectroscopy: Vibrational Spectroscopy is a subset of spectroscopy 
which analyses vibrations within a molecule (or material). The vibrations are characteristic of the 
molecular structure and, in polyatomic molecules, give rise to a spectroscopic “fingerprint”. The 
spectrum of vibrational energies or frequencies (expressed as wavenumbers, cm
-1
) can thus be 
employed to characterise a molecular structure, or changes to it due to the local environment or 
external factors (radiation, chemical agents). Vibrational energies fall within the mid Infrared (IR) 
region of the electromagnetic spectrum and are commonly probed through IR absorption 
spectroscopy. High energy or frequency vibrations are characteristic of light, tightly bound groups 
such as C-H, N-H and O-H, whereas low frequencies are associated with heavier groups, or collective 
vibrations such as ring breathing or skeletal stretches in macromolecules (Figure 4). 
IR spectroscopy is now a routine technique for materials characterisation and has found numerous 
applications in forensics, environmental science and pharmacology
31
. Applications to tissue samples 
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for (cancer) diagnostic applications were first reported in the early 90s, and since this time a range of 
pathologies has been investigated
32
. 
Wu et al. demonstrated that, on the basis of lipid and protein content, normal and tumor oral tissues 
can be discriminated
33
. In another study, of 10 normal sub-gingival tissues (NST) and 15 oral 
squamous cell carcinoma (SCC) tissues, Fukuyama et al. demonstrated that the normal spectra are 
strongly influenced by the presence of collagen. They also suggested that spectra are influenced by 
keratin, which exists in the ectodermal cells
34
. Study using FTIR spectroscopy to understand oral 
carcinogenesis in animal models have also been reported 
35
. FTIR imaging methods have also been 
explored to analyze different aspects of oral cancers. A study by Schultz et al., to assess changes in 
biochemistry of well and poorly differentiated oral/oropharyngeal SCC by infrared 
microspectroscopy, demonstrated that DNA and keratin can provide spectral markers to differentiate 
between normal and SCC biopsies
36
. Bruni et al., by generating three-dimensional IR chemical maps, 
demonstrated that proliferating and regressive states of head and neck tumours can be identified
37
. 
Towards high throughput, automated analysis, Pallua et al. demonstrated that good quality FTIR 
images can be obtained from formalin fixed paraffin embedded tissue microarray sections providing 
molecular level information as the basis for diagnosis
38
.  
Compared to fluorescence, FTIR provides a detailed fingerprint of the biochemical content of the 
sample. However, although FTIR has been used for the analysis of human tissues ex vivo, the 
application of this method for in vivo diagnosis is limited, due to the short penetration depth and the 
fact that water is highly absorptive in the mid-IR range. Conventional optical fibres have limited 
transparency in the IR region, and therefore, in vivo studies are less frequent than fluorescence or 
Raman fibre optical applications. New developments based on attenuated total reflection (ATR) 
elements might help in implementing in vivo applications.  
Raman spectroscopy: Raman spectroscopy is a complementary technique to FTIR and has its origin 
in the discovery of the Raman effect in 1928, for which C.V. Raman was awarded the Nobel prize in 
1930
39
. Similar to IR spectroscopy, Raman entails the coupling of incident radiation with molecular 
vibrations and the resultant spectrum is similarly characteristic of the material. However, whereas IR 
spectroscopy involves the absorption of radiation, Raman spectroscopy is a scattering technique, 
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whereby the incident radiation couples with the vibrating polarisation of the molecule and thus 
generates or annihilates a vibration. The differing underlying mechanisms results in a 
complementarity of the techniques. Vibrations of asymmetric, polar bonds thus tend to be strong in IR 
spectra, whereas Raman is particularly suitable as a probe of symmetric, nonpolar groups. Notably, O-
H vibrations of water are very strong in IR spectra, but are extremely weak in Raman spectra, 
rendering Raman a potentially more suitable technique for in vivo applications (Figure 3). A further 
implication of the differing physical origins of the techniques is that, whereas IR monitors the 
absorption of IR radiation, Raman scattering can be employed in the UV, visible or near IR regions of 
the spectrum (Figure 2). Raman scattering thus offers intrinsically higher spatial resolution for 
mapping or profiling in a confocal microscopy mode, the limit of spatial resolution being determined 
by the wavelength (<1µm for Raman, ~5-10 µm for IR). The application of Raman spectroscopy to 
biomolecules was first demonstrated as early as the 1960s and by the 1970s biomedical applications 
were explored
40
. Whole cell, tissue and in vivo studies carried out on a range of pathologies have 
demonstrated the potential for diagnostic applications
41
. 
Raman spectroscopic applications in oral cancer diagnostics started with the analysis of normal and 
dysplastic tissue in a rat model by Schut et al. (2000). Dysplasia in the palate was induced by topical 
application of the carcinogen 4-nitroquinoline 1-oxide and sensitivity and specificity of 100% were 
observed
42
. This was followed by a study of human oral cancer biopsies by Venkatakrishna et al., they 
recorded spectra of 49 biopsies and obtained an average classification efficiency of 88%
43
. In 2004, a 
study carried out by Krishna et al. demonstrated the applicability of formalin fixed oral tissues for 
optical pathology, revealing significant differences in the epithelial region of normal and malignant 
samples, arising from the protein composition, conformational/structural changes, and possible 
increase in protein content in malignant epithelia
44
. In 2006, Malini et al. demonstrated the efficacy of 
Raman spectroscopic methods in discriminating normal, cancerous, precancerous and inflammatory 
conditions
45
. Lipid rich features in normal conditions and prominent protein features in tumors and 
other pathological conditions were observed. Classification between different groups using 
multivariate statistical methods produced 100% sensitivity and specificity
45
. Raman mapping of tissue 
sections further elucidated biochemical changes within different epithelial layers which are associated 
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with disease onset
46
. A study by Sunder et al. demonstrated that oral carcinomas of different 
pathological grades can also be differentiated on the basis of the relative intensities of bands 
associated with lipids and proteins
47
.  
 In vivo Raman spectroscopy using fibreoptic probes for identifying site specific variations in 
the oral cavity was reported by Guze et al. in 2009, indicating that different oral sites can be 
discriminated on the basis of level of keratinization
48
. Bergholt et al., (2011), characterized the Raman 
spectroscopic profiles of different oral cavity regions (inner lip, attached gingiva, floor, dorsal tongue, 
ventral tongue, hard palate, soft palate, and buccal mucosa)
49
. Fitting of reference biochemicals 
(hydroxyapatite, keratin, collagen, DNA, and oleic acid) and partial least squares-discriminant 
analysis (PLS-DA) were employed to assess the inter-anatomical variability. The findings suggest that 
histological and morphological characteristics of different sites have a significant influence on the in 
vivo Raman spectra, and different sites can be classified with an overall sensitivity and specificity of 
85%
49
 .  Singh et al. demonstrated that in vivo spectra can be acquired in clinically implementable 
timescales and demonstrated the feasibility of classification of normal and pathological conditions
50
. 
This was followed by another study exploring tobacco induced cancer field effects in the oral 
mucosa
51
.  Sahu et al. demonstrated that in vivo Raman spectroscopy methods can also be utilized to 
understand age-related changes in the oral mucosa
52
. These findings were further verified by a recent 
study showing anatomical variability and feasibility of identifying pathological conditions with in 
vivo Raman spectroscopy 
53
. 
Minimally invasive methods in oral cancer diagnosis: Bio fluids such as blood, urine, lymph, and 
saliva can provide substantial information about human health and are being widely investigated for 
clinical diagnosis of various diseases including oral cancers. The attraction of these specimens lies in 
the fact that they can be used for mass screening, due to ease in collection, transport and low cost
54
. 
Studies have been carried out on physiochemical properties of saliva using surface enhanced laser 
desorption and ionization time of flight (SELDI-TOF) coupled with mass spectrometry (MS) and high 
performance liquid chromatography (HPLC) to identify proteomic and enzymatic markers associated 
with oral cancer
55
. Other techniques such as laser-induced fluorescence coupled with HPLC, and 
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capillary electrophoresis coupled mass spectroscopy have been employed to characterise salivary 
metabolites in oral cancer patients
56,57
.  
Recently, optical methods based on Raman, infrared absorption, and fluorescence 
spectroscopies have also been exploited for such investigations.  For example, enhanced levels of 
porphyrin in blood have been used as a diagnostic marker for various cancers including oral 
cancers
58,59
.  Yuvaraj et al. characterized different salivary metabolites associated with oral cancers by 
fluorescence spectroscopy
60
. FTIR spectroscopy has been applied to study sputum in order to 
diagnose oral cancers and discrimination between normal and cancerous samples was achieved on the 
basis of changes in the protein and glycoprotein structure within cells
61
. Surface-Enhanced Raman 
spectroscopy methods (SERS) have been used to differentiate between normal and oral cancer 
patients using spectra acquired from saliva
62
. A recent study by Elumalai et al. demonstrated that 
Raman spectroscopy of urine samples of healthy subjects and oral cancer patients can offer potential 
diagnostic information with a discrimination accuracy of 94%
63
.  The analysis of exfoliated oral cells 
by optical methods also holds enormous promise for early disease detection and diagnosis. Diem and 
co-workers have carried out multiple studies on spectral cytopathology of oral exfoliated cells
64,65
. 
Their findings are suggestive of the tremendous potential of spectroscopic methods in identifying 
minor changes associated with disease onset. Nevertheless, diagnosis based on biofluids suffers from 
limitations such as low analyte concentration, longer acquisition time, prone to experimental errors 
etc. Considerable efforts have been undertaken to develop standard protocols and sensitive 
instrumentation. Signal enhancements with the help of nano-particles or surface coating is an active 
area of research 
66
. Concentration of samples using centrifugal filtration devices has been shown to 
offer an alternative which allows measurement of the analytes in the native aqueous environment
67
. 
This also allows fractionation according to molecular weight of the constituent analytes, potentially 
allowing the targeting of molecular biomarkers of a disease. Appropriate modification in the 
instrumentation, especially automation for collection and analysis of body fluids is also an area which 
requires constant development. Efforts should also be undertaken for large scale trials and database 
development to overcome inter-laboratory and instrument variabilities 
68
.  
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Summary and Outlook 
Although the oral cavity is easily accessible to inspection, oral cancer patients often present at an 
advanced stage when treatment is less successful, thereby leading to high morbidity and mortality. 
Early detection is the best way to ensure patient survival and quality of life. The current gold standard 
for clinical diagnosis of oral lesions is biopsy and subsequent histopathological confirmation. The 
process is invasive, time-consuming and prone to inter-observer variability. An alternate method of 
diagnosis that can enable non-invasive diagnosis of the oral cavity in individuals with suspicious oral 
lesions is warranted.  
It is now well recognized that techniques based on optical spectroscopy can play a very 
important role towards this end. Spectroscopic measurements of tissue biochemistry, with sensitivity 
and specificity to localize changes enhanced by imaging, represent a measure of health (or disease) 
unattainable in current practice, and can provide sensitivities for early stage detection of biochemical, 
rather than simply morphological, abnormalities. Table 1 lists the advantages and disadvantages of the 
current screening/diagnostic methods and optical spectroscopy methods. Among the spectroscopic 
techniques described, fluorescence is perhaps the most technologically accessible, as it is simply 
based on the analysis of light which is emitted after illumination with a UV lamp. The emitted light is 
in the visible range and therefore probes can use free space or low grade, inexpensive fibre optics. The 
technique detects only the small fraction of endogenous biomolecules which are fluorescent, however, 
and relies on identifying pathology specific biomarkers amongst them. FTIR spectroscopy, on the 
other hand, produces a label free fingerprint of the complete biochemical content of the tissue, cell or 
biofluid, and this can explore more global and specific pathological changes. However, water is an 
extremely strong FTIR absorber, and so in vivo diagnostic applications may be limited. Raman 
spectroscopy provides a similar complete, label free fingerprint of the sample, and also couples to 
benefits of working in the visible region of the spectrum. Water is a weak Raman scatterer, and so the 
technique is more adaptable to routine in vivo patient screening or ex vivo spectral histology or 
cytology. The prospect is therefore of a high sensitivity and specificity, automatable, objective 
quantitative label free probe of early stage disease development and progression, based on the 
biomolecular content of the patient sample.  
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Variable thickness and degree of keratinisation at different sites in the oral cavity can 
influence the diagnostic efficacy of optical methods, especially for early lesions. This issue has been 
addressed extensively by the biomedical spectroscopic community. Various studies have successfully 
demonstrated the potential of spectroscopic methods in identifying anatomical variability due to 
different levels of keratinization
19,28,29,48,49
. These studies have provided evidence in support of 
inherent differences between different locations and suggested that each site be treated independently. 
For example, spectral models developed using spectra from buccal mucosa cancers cannot be used for 
identifying abnormalities at tongue or palate. Most of the recent studies have been performed under 
these guidelines, where tumors of specific sites are treated separately
50-53
. As with all optical 
techniques, the depth sensitivity is limited by the absorption and scattering of the tissue. Operation in 
the near infrared can optimise the depth sensitivity of Raman probes, and novel methodologies such 
as spatially offset Raman spectroscopy (SORS) promise increased penetration depths of several 
millimetres for deeper set lesions 
69
. Such technological advances potentially place Raman ahead of 
the field as candidate for in vivo optical diagnostic applications. 
In the coming years, large scale clinical trials must be conducted to gain the amount of site-
specific data necessary for developing adequate size training and test sets for robust algorithm 
development and analysis. The standard models for each of the individual sites in the oral cavity 
should be tested rigorously, preferably double-blinded, as multi-centric studies, before they are 
considered for routine use. Several technological advances in terms of fiberoptic probes and 
miniaturization of instruments are also required for real time and routine diagnosis. Efficient 
suppression of background signal, optimization of collection optics, and incorporation of miniaturized 
interference filters in the fiber probes are some of the issues that are to be addressed effectively. 
Further improvements in data analysis algorithms are also required for developing less cumbersome, 
rapid, unambiguous, objective and user friendly interfaces from the point of view of routine clinical 
use where a clinician or a technician can analyze a given spectrum against all available models to 
diagnose a case. The prospective adaptation of optical spectroscopy methods for routine clinical 
diagnosis would decrease the number of follow-up clinic visits and patient anxiety by minimizing 
14 
 
waiting times for histopathological diagnosis. The technology poses no known risks to the patients, 
and therefore could be a safe alternative/adjunct to the current diagnostic methods. 
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Figure legends 
 
Figure 1: Clinical presentation of tongue- cancer (A), leukoplakia (B) and lichen planus (C)  
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Figure 2: A schematic of the typical application of optical spectroscopic techniques for diagnostic 
applications. The light source is delivered via a probe or microscope (for in-vivo or ex vivo/in-vitro 
applications respectively) to the sample (cells, tissue or biofluid). Upon excitation by an appropriate 
source, molecules can either; go to an excited state and reemit light in the form of fluorescence 
(UV/visible lamp), absorb the light to generate vibrations within the molecules (Infrared lamp), or, by 
interaction with the vibrational modes of the molecules in the cells; the light is Raman scattered 
(visible or near infrared laser). The emitted/transmitted/scattered light is then collected by the probe or 
microscope and passed to a detector. The operator can then perform analysis on the resulting spectra 
and, using a prepared classifier, the output can for example be a yes, no, or maybe for the presence of 
cancer.  The technique can be modified according to the application; in-vivo, ex-vivo (histological or 
cytological) or in vitro.  
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Figure 3: Comparison of typical fluorescence spectrum (riboflavin) and typical Raman spectrum of 
tissue (both normalised) plotted on an energy scale. The intrinsic bandwidth of the fluorescence 
feature is very broad, compared to the Raman spectrum, which has a multitude of narrow bands which 
are shifted from the source wavelength of 785nm (~1.6eV). The energy shift of the Raman band is a 
measure of the vibrational energy and for comparison with infra red spectroscopy is usually expressed 
in wavenumbers (1/cm). Note the energy scales for the two spectra are different. 
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Figure 4: Comparison of typical IR absorption and Raman spectra of human tissue samples. The IR 
spectrum is in the mid infrared region of the spectrum, and the spectrum is less rich in information 
than the Raman spectrum. The Raman spectrum is expressed as wavenumber shift from the source 
laser line, although as shown in Figure 3, the scattered light is in the visible region of the spectrum. 
Both show typical features of lipids (●), proteins (▲), carbohydrates (■) and nucleic acids (♦). Note 
the strong absorption due to trace water in the FTIR spectrum in the region of ~3300cm
-1
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